The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

Inclusion Criteria: 1. Male and female aged 20 yrs or greater 2. Patients diagnosed with Hunner lesion in IC(interstitial cystitis)/BPS(Bladder Pain Syndrome) and who is scheduled to undergo transurethral resection 3. Symptom persisted more than 6 months 4. Pain VAS ≥4 Exclusion Criteria: 1. History of augmentation cystoplasty or previous transurethral coagulation/resection due to IC/BPS 2. Child-bearing potential, pregnant or nursing women. 3. Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination. 4. Urinary tract infection during run-in periods. 5. Genitourinary tuberculosis or bladder,urethral and prostate cancer 6. Recurrent urinary tract infection 7. History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate operation or treatment etc within 6months. 8. Neurologic disease history of cerebral infarction,multiple sclerosis or parkinsonism etc.- 9. Using a indwelling catheter or execution of intermittent self catheterization